On May, 10 Prestige Brands Holdings, Inc. (PBH) Analysts See $0.61 EPS

April 17, 2018 - By Russell Jones

Prestige Brands Holdings, Inc. (NYSE:PBH) Corporate Logo
Big Money Sentiment decreased to 1.12 in 2017 Q4. It has change of 0.52, from 2017Q3’s 1.64. The ratio fall due to Prestige Brands Holdings, Inc. positioning: 26 sold and 72 reduced. 33 funds took positions and 77 increased positions. Investors holded 56.08 million in 2017Q3 but now own 59.33 million shares or 5.79% more.
Rhumbline Advisers reported 114,607 shs. Cs Mckee Ltd Partnership holds 0.12% of its capital in Prestige Brands Holdings, Inc. (NYSE:PBH) for 36,650 shs. Us Financial Bank De holds 0% or 2,158 shs in its capital. State Treasurer State Of Michigan holds 19,100 shs. New York-based Amalgamated Bank has invested 0.01% in Prestige Brands Holdings, Inc. (NYSE:PBH). Manufacturers Life Insurance Company The owns 126,488 shs or 0.01% of their US capital. Alliancebernstein Lp owns 85,815 shs. Martingale Asset Management Limited Partnership holds 0.03% or 50,617 shs. Clark Capital Mgmt Group invested 0.03% in Prestige Brands Holdings, Inc. (NYSE:PBH). Johnson Counsel, Ohio-based fund reported 14,280 shs. New York-based Art Advsr Lc has invested 0.11% in Prestige Brands Holdings, Inc. (NYSE:PBH). Tiverton Asset Mgmt Llc holds 0.05% or 17,618 shs in its capital. Hsbc Hldgs Public Ltd Liability Company invested in 45,365 shs. The Ohio-based Fifth Third Bank has invested 0% in Prestige Brands Holdings, Inc. (NYSE:PBH). Voya Limited Liability holds 0.13% or 1.37M shs in its capital.

Investors expect Prestige Brands Holdings, Inc. (NYSE:PBH)’s quarterly earnings on May, 10., according to Faxor. Analysts predict $0.61 EPS, which is $0.07 up or 12.96 % from 2017’s $0.54 EPS. This could hit $32.35M profit for PBH assuming the current $0.61 EPS will become reality. Wall Street now sees -12.86 % negative EPS growth despite Prestige Brands Holdings, Inc. last quarter’s EPS of $0.70. Its shares touched $32.15 on during the last trading session after 2.49% change.Currently Prestige Brands Holdings, Inc. is downtrending after 40.38% change in last April 17, 2017. PBH has 579,813 shares volume. PBH underperformed by 51.93% the S&P 500.

Prestige Brands Holdings, Inc. (NYSE:PBH) Ratings Coverage

Total analysts of 5 have positions in Prestige Brand Holdings (NYSE:PBH) as follows: 3 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 60%. Since November 2, 2017 according to StockzIntelligence Inc Prestige Brand Holdings has 7 analyst reports. The company rating was upgraded by BMO Capital Markets on Wednesday, November 15. On Monday, December 4 the stock has “Outperform” rating by William Blair. On Monday, February 5 the stock of Prestige Brands Holdings, Inc. (NYSE:PBH) earned “Overweight” rating by KeyBanc Capital Markets. On Monday, February 5 the firm has “Neutral” rating by DA Davidson given. On Friday, February 2 the firm has “Hold” rating by DA Davidson given. In Friday, February 2 report Jefferies maintained it with “Hold” rating and $43.0 target. On Thursday, November 2 the stock of Prestige Brands Holdings, Inc. (NYSE:PBH) earned “Hold” rating by Jefferies.

Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, makes, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally.The company has $1.71 billion market cap. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning divisions.4.41 is the P/E ratio. The company??s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies.

Prestige Brands Holdings, Inc. (NYSE:PBH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: